This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Novavax (NVAX)

Tipranks - Tipranks - Sat Jun 13, 5:16AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biomea Fusion (BMEA) and Novavax (NVAX) with bullish sentiments.

Introducing TipRanks MCP for Agents

Biomea Fusion (BMEA)

Citi analyst Yigal Nochomovitz maintained a Buy rating on Biomea Fusion yesterday and set a price target of $7.00. The company’s shares closed last Thursday at $1.19.

According to TipRanks.com, Nochomovitz is a 4-star analyst with an average return of 8.3% and a 42.9% success rate. Nochomovitz covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, ArriVent BioPharma, Inc., and Arvinas Holding Company. ;'>

Biomea Fusion has an analyst consensus of Moderate Buy, with a price target consensus of $7.20, representing a 520.7% upside. In a report issued on June 3, H.C. Wainwright also maintained a Buy rating on the stock with a $4.00 price target.

See today’s best-performing stocks on TipRanks >>

Novavax (NVAX)

In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Novavax, with a price target of $19.00. The company’s shares closed last Thursday at $9.03.

According to TipRanks.com, Shrader is a 4-star analyst with an average return of 5.8% and a 38.0% success rate. Shrader covers the Healthcare sector, focusing on stocks such as NeOnc Technologies Holdings, Inc., Alto Neuroscience, Inc., and Coya Therapeutics, Inc. ;'>

Novavax has an analyst consensus of Hold, with a price target consensus of $12.83.

Read More on BMEA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).